Hello, welcome to Pharmaceutical Network

| register | Product exhibition hall | Collect this shop
Close the exhibition hall

four billion five hundred and eighty-nine thousand

recommend product

/ recommend product

more

product Exhibition

/ Latest Products

ABOUT US

About us
Belenko Pharmaceutical Technology (Shanghai) Co., Ltd. (hereinafter referred to as Belenko) is a technology group enterprise providing process solutions for the field of life science, focusing on the R&D and manufacturing of key process equipment and consumables for vaccines, antibody drugs, cell therapy, gene therapy and other biological products. Its products cover upstream cell culture Process units and process development services such as one-time storage solution preparation and downstream chromatography, ultrafiltration, filtration, etc. Bailingke is committed to continuously providing customers with high-quality innovative products and solutions, and creating an efficient, safe and competitive biopharmaceutical supply chain ecosystem. Since its establishment in April 2021, Belenko has developed rapidly. It has built a production base for disposable storage fluid consumables for biopharmaceuticals, a production base for chromatography fillers and a research and development center, with more than 400 employees. With strong R&D and production strength, the company has launched a series of products, including disposable solution preparation bags, liquid storage bags, sampling bags, freeze-thaw bags, ultrafiltration systems, solution preparation and storage systems, chromatography fillers, software control systems and other biotechnology related products. Belenko's products have now entered many domestic biopharmaceutical enterprises and are used in antibodies, vaccines Learn more

Technology Center

Technical Center
  • 06-14 two thousand and twenty-four
    Risk and control strategy of purification process amplification

    Before listing, the process development of biological products can be divided into three stages, namely pre clinical stage, phase I and phase II clinical stage, phase III clinical stage and commercial production stage. Generally, the scale of the three stages is not the same, so two process transfers are often accompanied by process amplification. Figure 1 Biological Product Process Development Stage

  • 06-12 two thousand and twenty-four
    Precautions for E&L analysis and test

    Considering the difference between small molecule drugs and large molecule drugs is helpful to determine the analysis and test method of E&L. The analysis of extractable and extractable substances (E&L) is essential to determine the relevant toxicological risks and ensure the safety of the drug product. The inspection of extractable substances is helpful to identify those that can pollute or affect the quality of drugs

  • 06-07 two thousand and twenty-four
    Safety considerations in ADC field

    Antibody drug conjugate (ADC) refers to a class of biotechnology drugs that couple small molecule compounds (Payloads) to targeted antibodies or antibody fragments through linkers. along with

  • 05-31 two thousand and twenty-four
    Cleaning and life of Protein A affinity filler

    Thanks to the high selectivity and volume removal rate of ProteinA affinity filler for antibodies and the robust impurity removal effect. ProteinA affinity filler is the industry standard for antibody drug production due to the limitations of ProteinA binding capacity and the high level of protein A resin

  • 05-30 two thousand and twenty-four
    Purification Tips | MaXtar ® COLL 400/700 virus application sharing

    There is such a special kind of packing in the multi mode chromatography packing family of Bellinturk. With its unique packing structure, it plays the dual characteristics of gel filtration and adsorption chromatography and is specially designed for super molecules. Including MaXtar ® COLL400, MaXtar ® COLL700

  • 05-29 two thousand and twenty-four
    Process characterization and verification

    FDA defines process validation as "establishing documentary evidence that a specific process will continue to produce products that meet predetermined specifications and quality attributes". This regulatory requirement reflects the recognition that product quality may be materially affected by the production process. In order to meet this requirement, the process needs to be fully characterized and

  • 05-24 two thousand and twenty-four
    Research and development direction and process support of new veterinary vaccine

    Animal vaccines belong to the category of veterinary biological products. Veterinary biological products are an important part of biological products. Because of many shortcomings of traditional vaccines and the development of science and technology, many new vaccines, including recombinant vaccines, have become the focus of research. Scale of animal health industry I. Genetic engineering vaccine

  • 05-23 two thousand and twenty-four
    Purification Tips | Cation Exchange Chromatography Medium in Antibody Separation

    In the classic three-step method of antibody purification, affinity capture+cation exchange+anion exchange, we have introduced the Berindac anion exchange chromatography medium at an early stage. See [purification tips | anion exchange chromatography medium in antibody separation]. Today, we will focus on the introduction of Berindac cation exchange chromatography medium. Berindac cation exchange

Member Login

Please enter the account number

Please input a password

=

Please enter the verification code

Collect this shop

label:
Saved successfully

(Space separation, 3 at most, and 10 characters for a single label at most)

Common:

Tips

Your message has been submitted successfully! We will reply to you at the first time~
Online Message